tiprankstipranks
Maxim Group Remains a Hold on BioNano Genomics (BNGO)
Blurbs

Maxim Group Remains a Hold on BioNano Genomics (BNGO)

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Hold rating on BioNano Genomics (BNGOResearch Report). The company’s shares opened today at $1.26.

According to TipRanks, McCarthy is an analyst with an average return of -23.3% and a 24.75% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Annovis Bio, Acurx Pharmaceuticals, and SELLAS Life Sciences Group.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for BioNano Genomics with a $9.00 average price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $20.20 and a one-year low of $1.15. Currently, BioNano Genomics has an average volume of 1.73M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

BioNano Genomics (BNGO) Company Description:

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

Read More on BNGO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles